Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials
8
Zitationen
19
Autoren
2024
Jahr
Abstract
BACKGROUND: Medical record review by a physician clinical events committee is the gold standard for identifying cardiovascular outcomes in clinical trials, but is labor-intensive and poorly reproducible. Automated outcome adjudication by artificial intelligence (AI) could enable larger and less expensive clinical trials but has not been validated in global studies. METHODS: We developed a novel model for automated AI-based heart failure adjudication (Heart Failure Natural Language Processing) using hospitalizations from 3 international clinical outcomes trials. This model was tested on potential heart failure hospitalizations from the DELIVER trial (Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure), a cardiovascular outcomes trial comparing dapagliflozin with placebo in 6063 patients with heart failure with mildly reduced or preserved ejection fraction. AI-based adjudications were compared with adjudications from a clinical events committee that followed Food and Drug Administration-based criteria. RESULTS: AI-based adjudication agreed with the clinical events committee in 83% of events. A strategy of human review for events that the AI model deemed uncertain (16%) would have achieved 91% agreement with the clinical events committee while reducing the adjudication workload by 84%. The estimated effect of dapagliflozin on heart failure hospitalization was nearly identical with AI-based adjudication (hazard ratio, 0.76 [95% CI, 0.66-0.88]) compared with clinical events committee adjudication (hazard ratio, 0.77 [95% CI, 0.67-0.89]). The AI model extracted symptoms, signs, and treatments of heart failure from each medical record in tabular format and quoted sentences documenting them. CONCLUSIONS: AI-based adjudication of clinical outcomes has the potential to improve the efficiency of global clinical trials while preserving accuracy and interpretability.
Ähnliche Arbeiten
"Why Should I Trust You?"
2016 · 14.618 Zit.
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
2005 · 10.531 Zit.
A Comprehensive Survey on Graph Neural Networks
2020 · 8.884 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.452 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.948 Zit.
Autoren
Institutionen
- Broad Institute(US)
- Brigham and Women's Hospital(US)
- Harvard University(US)
- S.P.E.C.I.E.S.(US)
- Massachusetts Institute of Technology(US)
- Massachusetts General Hospital(US)
- Texas Cardiac Arrhythmia(US)
- University of Minnesota(US)
- Minneapolis VA Health Care System(US)
- Minneapolis VA Medical Center(US)
- Palo Alto University(US)
- Stanford University(US)
- British Heart Foundation(GB)
- University of Glasgow(GB)
- Beth Israel Deaconess Medical Center(US)